Elevance Health (ELV) Cash & Current Investments (2009 - 2026)

Elevance Health (ELV) has 18 years of Cash & Current Investments data on file, last reported at $35.6 billion in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $35.6 billion, up 332.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.6 billion (up 332.89% YoY), and the FY2025 annual result was $10.2 billion, down 69.45% from the prior year.
• Cash & Current Investments improved to $35.6 billion in Q1 2026 per ELV's latest filing, from $10.2 billion in the prior quarter.
• Over five years, Cash & Current Investments peaked at $36.1 billion in Q4 2023 and troughed at $6.7 billion in Q1 2024.
• A 5-year average of $19.5 billion and a median of $10.5 billion in 2023 frame the typical range for Cash & Current Investments.
• On a YoY basis, Cash & Current Investments climbed as much as 377.48% in 2025 and fell as far as 69.45% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $33.3 billion in 2022, then grew by 8.4% to $36.1 billion in 2023, then declined by 7.34% to $33.5 billion in 2024, then plunged by 69.45% to $10.2 billion in 2025, then surged by 247.59% to $35.6 billion in 2026.
• Business Quant data shows ELV's Cash & Current Investments at $35.6 billion in Q1 2026, $10.2 billion in Q4 2025, and $35.0 billion in Q3 2025.